News
Vanguard's mid-cap value ETF has delivered a 106% total return over the last ten years. It's also well-diversified with $15 billion in AUM and has a low 0.07% expense ratio. This article compares ...
Hosted on MSN15d
ETFs to Capitalize on the Novo Nordisk-Septerna DealThis put the spotlight on healthcare ETFs, which could be the best way for investors to tap the opportunity arising from the proposed deal. Investors should keep a close eye on the movement of ...
all the Energy ETFs here). If it materializes, the deal will reshape the competitive landscape of the U.S. oil sector, uniting two of the biggest acreage holders in the Permian Basin of Texas and ...
The downside protection and higher upside caps make these one of the most attractive deals in the markets right now. The downside protection and higher upside caps make these one of the most ...
Valerio Baselli: Hello, welcome to Morningstar. The big news within the ETF space is that the American asset-management firm ARK Invest, which specializes in disruptive innovation, has acquired ...
Novo Nordisk recently announced a $1.75 billion acquisition deal with Lexicon Pharmaceuticals LXRX for an experimental oral obesity treatment. Roundhill GLP-1 & Weight Loss ETF is the world’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results